Celltrion’s Bone Disease Biosimilars Get Approval in U.S.
Seoul: Celltrion Inc., a major South Korean biopharmaceutical firm, announced that its two new biosimilars for bone disease treatment have obtained approval from the United
Seoul: Celltrion Inc., a major South Korean biopharmaceutical firm, announced that its two new biosimilars for bone disease treatment have obtained approval from the United
Seoul: Celltrion Inc., a major South Korean biopharmaceutical firm, announced that its two new biosimilars for bone disease treatment have obtained approval from the United
Seoul: Homeplus Co., a discount store chain in South Korea, announced it has entered a court-led rehabilitation process following a decline in its credit rating
Seoul: Homeplus Co., a discount store chain in South Korea, announced it has entered a court-led rehabilitation process following a decline in its credit rating
Seoul: South Korea announced its commitment to continue supporting Ukraine’s peace and reconstruction efforts following U.S. President Donald Trump’s suspension of military aid to Kyiv.
Seoul: The latest trading session for the KOSPI 200 index witnessed notable fluctuations, with various companies experiencing changes in their stock prices. HYOSUNG HEAVY and
Seoul: Hyundai Motor Co. reported a 2.1 percent increase in its February sales compared to the previous year, driven by a significant boost in domestic
Seoul: Hyundai Motor Co. reported a 2.1 percent increase in its February sales compared to the previous year, driven by a significant boost in domestic
Copyright ©2026 Korea News Gazette. All Rights Reserved.